Finance Watch: Q2 Saw Fewer, But Larger, Venture Capital Deals
BGV Closed New Europe-Focused €150m VC Fund
Private Company Edition: Fewer biotech companies raised venture capital in the second quarter, but the amount of capital raised was on par with the first quarter. Also, former BMS R&D exec Rupert Vessey joined Flagship Pioneering, two new VC funds emerged and Septerna raised a $150m series B round.
